{{item.title}}
{{item.text}}
{{item.title}}
{{item.text}}
Pharmaceutical and life sciences
Helping clients better compete in an evolving health market and improve cost-efficiency and profitability.
Top industry issues – video perspectives from our leaders
In this video series, PwC's Pharmaceutical and Life Sciences leaders help you navigate through top issues and offer practical guidance on your most pressing sector challenges. Our PLS practice helps organizations – from those who develop drugs, to those who manufacture medical devices – connect to consumer needs and develop and deliver tomorrow's treatments. We deliver effective solutions to the complex strategic, operational, and financial challenges facing our industry.
The potential impact of tax reform on pharmaceutical and life sciences companies
From President Trump's tax plan to health care reform - we break down developments from Washington and what companies in our industry need to do to anticipate and prepare for legislative change.
{{filterContent.facetedTitle}}
{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Contact us
Karen C. Young
US Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (973) 236 5648
Email
Michael Swanick
Global Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (267) 330 6060
Email
Kathleen Michael
US Health Industries Tax Leader, PwC US
Tel: +1 (973) 236 4210
Email
Douglas Strang
Global Pharmaceutical and Life Sciences Advisory Leader, PwC US
Tel: +1 (267) 330 3045
Email
Follow us
